JP2013529080A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529080A5
JP2013529080A5 JP2013510643A JP2013510643A JP2013529080A5 JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5 JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5
Authority
JP
Japan
Prior art keywords
dom7h
seq
variant
variable domain
single variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529080A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/058298 external-priority patent/WO2011144751A1/en
Publication of JP2013529080A publication Critical patent/JP2013529080A/ja
Publication of JP2013529080A5 publication Critical patent/JP2013529080A5/ja
Pending legal-status Critical Current

Links

JP2013510643A 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体 Pending JP2013529080A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34651910P 2010-05-20 2010-05-20
US61/346,519 2010-05-20
PCT/EP2011/058298 WO2011144751A1 (en) 2010-05-20 2011-05-20 Improved anti-serum albumin binding variants

Publications (2)

Publication Number Publication Date
JP2013529080A JP2013529080A (ja) 2013-07-18
JP2013529080A5 true JP2013529080A5 (enExample) 2014-07-03

Family

ID=44352234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510643A Pending JP2013529080A (ja) 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体

Country Status (13)

Country Link
US (2) US9040668B2 (enExample)
EP (1) EP2571900A1 (enExample)
JP (1) JP2013529080A (enExample)
KR (1) KR20130109977A (enExample)
CN (1) CN103003303A (enExample)
AU (1) AU2011254559B2 (enExample)
BR (1) BR112012029280A2 (enExample)
CA (1) CA2799633A1 (enExample)
EA (1) EA201291009A1 (enExample)
IL (1) IL222802A0 (enExample)
MX (1) MX2012013406A (enExample)
SG (1) SG185437A1 (enExample)
WO (1) WO2011144751A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
JP6408998B2 (ja) 2012-12-21 2018-10-17 サノフイSanofi 二重glp1/gipまたは三方glp1/gip/グルカゴンアゴニスト
EP3080149A1 (en) 2013-12-13 2016-10-19 Sanofi Dual glp-1/glucagon receptor agonists
TW201609799A (zh) 2013-12-13 2016-03-16 賽諾菲公司 雙重glp-1/gip受體促效劑
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
HRP20220080T1 (hr) * 2015-11-13 2022-04-15 Ablynx N.V. Poboljšane imunoglobulinske varijabilne domene koje vežu serumski albumin
IL263079B2 (en) 2016-05-18 2024-05-01 Modernatx Inc Polynucleotides encoding relaxin
CN120712282A (zh) 2023-02-17 2025-09-26 阿布林克斯有限公司 结合新生儿fc受体的多肽
WO2025021183A1 (zh) * 2023-07-27 2025-01-30 上海复宏汉霖生物医药有限公司 编码促肾上腺皮质激素的多核苷酸及其相关组合物和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
CA2492092A1 (en) 2002-06-28 2004-01-08 Greg Winter Immunoglobin single variant antigen-binding domains and dual-specific constructs
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
PL1737962T3 (pl) 2004-03-24 2011-02-28 Domantis Ltd Uniwersalny lider GAS1
JP2008500830A (ja) 2004-06-01 2008-01-17 ドマンティス リミテッド 増加した血清半減期を有する二重特異性融合抗体
KR20070094909A (ko) 2004-12-02 2007-09-27 도만티스 리미티드 혈청 알부민 및 glp-1 또는 pyy를 표적으로 삼는이중특이성 도메인을 갖는 항체
CA2640066A1 (en) 2006-01-24 2007-08-02 Roland Beckmann Fusion proteins that contain natural junctions
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
UA102993C2 (ru) 2007-06-06 2013-09-10 Домантис Лимитед Анти-vegf единичный вариабельный домен иммуноглобулина
EA200901494A1 (ru) * 2007-06-06 2010-06-30 Домантис Лимитед Способы селекции протеазоустойчивых полипептидов
AU2008328726B2 (en) 2007-11-30 2014-06-12 Glaxo Group Limited Antigen-binding constructs
SG173489A1 (en) * 2009-02-19 2011-09-29 Glaxo Group Ltd Improved anti-serum albumin binding variants
KR20110119806A (ko) * 2009-02-19 2011-11-02 글락소 그룹 리미티드 개선된 항­tnfr1 폴리펩티드,항체 가변 도메인 및 길항제
UY32452A (es) * 2009-02-19 2010-09-30 Glaxo Group Ltd Variantes de unión a anti-albúmina de suero mejoradas
EA021146B1 (ru) * 2009-03-27 2015-04-30 Глаксо Груп Лимитед Продукты слияния и конъюгаты лекарственных средств
CA2768460A1 (en) * 2009-07-16 2011-01-20 Glaxo Group Limited Antagonists, uses & methods for partially inhibiting tnfr1
MX2012003939A (es) * 2009-09-30 2012-07-30 Glaxo Group Ltd Fusiones y conjugados de farmaco.

Similar Documents

Publication Publication Date Title
JP2013529080A5 (enExample)
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
CN103619878B (zh) 结合血清白蛋白的蛋白
JP2009545319A5 (enExample)
CN110191896A (zh) 改进的血清白蛋白结合物
JP2017506075A5 (enExample)
JP2020186248A5 (enExample)
JP6333271B2 (ja) IL−1βへの結合メンバー
JP2014513953A5 (enExample)
CA3045726A1 (en) Improved serum albumin binding immunoglobulin single variable domains
JP2010502183A5 (enExample)
JP2013518853A (ja) 血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
JP2017500018A5 (enExample)
RS66173B1 (sr) Poboljšana veziva serumskog albumina
CN108473564A (zh) 改进的血清白蛋白结合剂
JP2018526989A5 (enExample)
CN115397852B (zh) 工程化抗il-2抗体
JP2009539349A5 (enExample)
JP2020521458A5 (enExample)
JP2010535032A5 (enExample)
JP2009528828A5 (enExample)
JP2010530220A5 (enExample)
EA034854B1 (ru) Анти-il-17-антитела, способ их получения и способ применения
JP2013543384A5 (enExample)
JP2015506945A5 (enExample)